Perceptive Advisors

Perceptive Advisors

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, New York


The primary office of this VC is located in New York. The VC's location is in North America, United States.

The fund has no specific requirements for the number of founders in a start-up. If there are 5+ founders in the start-up, the probability of getting the investment is low. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 7 other countries. The average start-up age at the time of investment by this fund is 6-10. Allogene Therapeutics, BridgeBio, Alector are among the most popular portfolio start-ups of the fund. Among their most successful investment fields, we have identified Genetics, Biopharma. Also, because of its portfolio diversification tendency, we can highlight 13 more industries for this fund.

The fund performance shows that this VC achieves 13 percentage points more exits in comparison to other VCs. We recorded the biggest number of exits for this fund in 2018. Perceptive Advisors participates, on average, in 28 percentage points more than the average amount of lead investments in other funds. At the time of investment by Perceptive Advisors, a typical start-up valuation would be 100-500 millions dollars. The most common rounds for this fund are in the range of 50 - 100 millions dollars. This fund was the most active in 2019. The fund usually participates in 2-6 investment rounds per year.

We also identified another 3 core personnel in our database.

The fund usually invests in rounds together with 5-6 others. Aside from Perceptive Advisors, start-ups are often funded by Third Rock Ventures, F-Prime Capital, Morgenthaler Ventures and 85 other funds. Other VCs who often invest in the same rounds are ArrowMark Partners, RTW Investments LLC, Viking Global Investors, the total number of co-investors is 85. The investors in the following rounds are usually OrbiMed, Pontifax, Warburg Pincus, and 16 VCs in total.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: last, first '.' last, first

Group Appearance [how often fund is operating separately from groups with shared interest]

96.7% of cases

Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

11.8% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

2.1 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.48 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Funds Investing in Previous

Third Rock Ventures, F-Prime Capital, Morgenthaler Ventures

Funds Investing in Following

OrbiMed, Pontifax, Warburg Pincus

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: